Goodman WK - Search Results

1

Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.

Greenberg BD, Gabriels LA, Malone DA Jr, Rezai AR, Friehs GM, Okun MS, Shapira NA, Foote KD, Cosyns PR, Kubu CS, Malloy PF, Salloway SP, Giftakis JE, Rise MT, Machado AG, Baker KB, Stypulkowski PH, Goodman WK, Rasmussen SA, Nuttin BJ. Greenberg BD, et al. Among authors: goodman wk. Mol Psychiatry. 2010 Jan;15(1):64-79. doi: 10.1038/mp.2008.55. Epub 2008 May 20. Mol Psychiatry. 2010. PMID: 18490925 Free PMC article. Clinical Trial.

2

Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.

McDougle CJ, Goodman WK, Price LH, Delgado PL, Krystal JH, Charney DS, Heninger GR. McDougle CJ, et al. Among authors: goodman wk. Am J Psychiatry. 1990 May;147(5):652-4. doi: 10.1176/ajp.147.5.652. Am J Psychiatry. 1990. PMID: 1970224

3

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.

Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS. Goodman WK, et al. Arch Gen Psychiatry. 1990 Jun;47(6):577-85. doi: 10.1001/archpsyc.1990.01810180077011. Arch Gen Psychiatry. 1990. PMID: 2112374 Clinical Trial.

4

Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.

DeVeaugh-Geiss J, Katz R, Landau P, Goodman W, Rasmussen S. DeVeaugh-Geiss J, et al. Psychopharmacol Bull. 1990;26(1):54-9. Psychopharmacol Bull. 1990. PMID: 2196627 Clinical Trial.

5

Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?

Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF. Goodman WK, et al. J Clin Psychiatry. 1990 Aug;51 Suppl:36-43; discussion 55-8. J Clin Psychiatry. 1990. PMID: 2199433 Review.

6

Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.

Chouinard G, Goodman W, Greist J, Jenike M, Rasmussen S, White K, Hackett E, Gaffney M, Bick PA. Chouinard G, et al. Psychopharmacol Bull. 1990;26(3):279-84. Psychopharmacol Bull. 1990. PMID: 2274626 Clinical Trial.

7

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.

Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS. Goodman WK, et al. Arch Gen Psychiatry. 1989 Jan;46(1):36-44. doi: 10.1001/archpsyc.1989.01810010038006. Arch Gen Psychiatry. 1989. PMID: 2491940 Clinical Trial.

8

Fluvoxamine as an antiobsessional agent.

Goodman WK, Price LH, Rasmussen SA, Heninger GR, Charney DS. Goodman WK, et al. Psychopharmacol Bull. 1989;25(1):31-5. Psychopharmacol Bull. 1989. PMID: 2505302 Review.

9

The Yale-Brown Obsessive Compulsive Scale. II. Validity.

Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. Goodman WK, et al. Arch Gen Psychiatry. 1989 Nov;46(11):1012-6. doi: 10.1001/archpsyc.1989.01810110054008. Arch Gen Psychiatry. 1989. PMID: 2510699

10

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. Goodman WK, et al. Arch Gen Psychiatry. 1989 Nov;46(11):1006-11. doi: 10.1001/archpsyc.1989.01810110048007. Arch Gen Psychiatry. 1989. PMID: 2684084

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

364 results

Search Page